Moderna reports positive data on early-stage coronavirus vaccine trial, shares surge

Moderna’s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday, sending the company’s shares surging more than 17%.